XML 46 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity The following table summarizes the activity related to the Company's stock options:
Options Outstanding
Outstanding Stock OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Life (in years)Aggregate Intrinsic Value
(in thousands)
Balance, January 31, 2022
6,620,701 $7.28 4.32$11,723 
Granted— $— 
Exercised(259,003)$2.76 
Forfeited or canceled(1,767,994)$10.11 
Balance, January 31, 2023
4,593,704 $6.45 3.09$5,020 
Vested and expected to vest4,593,704 $6.45 3.09$5,020 
Exercisable at January 31, 2023
4,593,704 $6.45 3.09$5,020 
Schedule of Nonvested Share Activity
Nonvested option activity is as follows:
OptionsWeighted-Average Grant Date Fair Value
Nonvested as of January 31, 2022
200,000 $6.06 
Granted— $— 
Vested— $— 
Forfeited(200,000)$6.06 
Balance as of January 31, 2023
— $— 
Schedule of Nonvested RSU Activity The following table summarizes the activity related to the Company's restricted stock and restricted stock units:
OutstandingWeighted-Average Grant Date Fair Value
Balance as of January 31, 2022
10,184,214 $14.38 
Granted10,067,783 $5.71 
Vested and converted to shares(4,898,655)$12.96 
Forfeited or canceled(3,788,475)$12.60 
Balance as of January 31, 2023
11,564,867 $8.00 
Schedule of Employee Stock Purchase Plan Valuation Assumptions The Black-Scholes option-pricing model assumptions used to calculate the fair value of shares, estimated at commencement to be purchased during an ESPP offering period were as follows:
Fiscal year ended January 31,
202320222021
Expected life (years)0.500.500.50
Expected volatility
48.87% - 63.52%
45.54% - 59.24%
51.44% - 65.48%
Dividend yield—%—%—%
Risk-free rate
0.86% - 3.78%
0.05% - 0.06%
0.12% - 0.29%
Schedule of Share-Based Compensation Expense The Company's stock-based compensation expense for the periods presented was as follows:
Fiscal year ended January 31,
(in thousands)202320222021
Cost of revenue$5,042 $7,099 $5,724 
Sales and marketing22,961 26,496 32,581 
Research and development16,401 20,654 17,071 
General and administrative18,674 19,231 16,918 
Total stock-based compensation expense$63,078 $73,480 $72,294